Consumer Involvement in decision making for health care policy and planning

Similar documents
Consumer-driven health care: Building partnerships in research

COMPUS Procedure Evidence-Based Best Practice Recommendations

On April 19, 2007, the National Working Group on

NICE Charter Who we are and what we do

Institute of Medicine Standards for Systematic Reviews

Patient-Oriented Research

NIHR COCHRANE COLLABORATION PROGRAMME GRANT SCHEME

NIHR Funding Opportunities

COMMISSIONING SUPPORT PROGRAMME. Standard operating procedure

Chapter 2: Evidence-Based Nursing Practice

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Access to Drugs Policy

Health Technology Assessment and Optimal Use: Medical Devices; Diagnostic Tests; Medical, Surgical, and Dental Procedures

METHODOLOGY. Transparency. Conflicts of Interest. Multidisciplinary Steering Committee Composition. Evidence Review

Overview of NIHR structure, and funding streams. Prof James Mason, Co-Director, RDS NE

1. The Department funds R&D through two main routes:

REQUEST FOR PROPOSAL

During the one session on value based assessment (VBA), the audience heard from 3 speakers:

The Rx for Change database: a first-in-class tool for optimal prescribing and medicines use

abcdefghijklmnopqrstu

13. Research utilization is essentially synonymous with evidence-based practice. A) True B) False

Still Being NICE After 14 Years

Health Technology Wales

How NICE clinical guidelines are developed

Research topic identification & the funding process

CADTH Patient Input Process Review

Clinical Development Process 2017

Inside. 3 Greetings. 5 About Us. 9 The Contextualized Health Research Synthesis Program. 17 Awards Programs. 19 Research Exchange Groups

National Institute for Health and Clinical Excellence. The guidelines manual

APPROACHES TO ENHANCING THE QUALITY OF DRUG THERAPY A JOINT STATEMENT BY THE CMA ANDTHE CANADIAN PHARMACEUTICAL ASSOCIATION

Drug Safety and Effectiveness. Canadian Association for Population Therapeutics April 21, 2009

Comparative Effectiveness: Implications for the Pharmaceutical Sector Health Policy Audioconference February 23, 2009

KNOWLEDGE SYNTHESIS: Literature Searches and Beyond

Horizon scanning.

European Patients Academy (EUPATI) Update

Health Services and Delivery Research Programme

Issue date: October Guide to the multiple technology appraisal process

National Guidelines for a Comprehensive Service System to Support Family Caregivers of Adults with Mental Health Problems and Illnesses SUMMARY

A Participation Standard for the NHS in Scotland Standard Document

RESPONSE TO RECOMMENDATIONS FROM THE HEALTH & SOCIAL CARE COMMITTEE: INQUIRY INTO ACCESS TO MEDICAL TECHNOLOGIES IN WALES

Submission to Canada s Fundamental Science Review Executive Summary and Recommendations

Course Code(s): PY011P31UV Part-Time 6 Months. University Statement of Credit University Statement of Credit

Patient-Centred Decision Making with MCDA: Should We Be Trying to Quantify the Patient Voice for Use in HTA?

Janssen Policy Evaluating and Responding to Pre-approval Access Requests for Investigational Medicines

Family Carers of Persons with Heart Failure. Presented by: Rick Greene, IACO and Susan Campbell, WomenHeart Adelaide, Australia

Health Technology Assessment (HTA) Good Practices & Principles FIFARMA, I. Government s cost containment measures: current status & issues

MULTIPLE CHOICE. Choose the one alternative that best completes the statement or answers the question.

Reducing Attendances and Waits in Emergency Departments A systematic review of present innovations

By to:

PhD Scholarship Guidelines

Nursing skill mix and staffing levels for safe patient care

Health Professionals, Decision Makers and Optimal Prescribing: Toward an Effective Strategy for All

Knowledge Translation: Cochrane Strategy to disseminate evidence

abcdefghijklmnopqrstu

FREE Know your rights

NURS Evidence Based Practice and Informatics Course

OCCUPATIONAL THERAPY AUSTRALIA NT/QLD DIVISION Clinical Research Bursary APPLICATION FORM AND GUIDELINES

Low Molecular Weight Heparins

Request for Applications Strategic Operating Grant for the Study of Medical Cannabis and Associated Cannabinoids

Table 1. NCLEX-RN ultimate pass rate of Manitoba graduates in Table 2. NCLEX-RN number of attempts taken by Manitoba graduates in 2015

Consensus Statement on the Mental Health of Emerging Adults: Making Transitions a Priority in Canada. Executive Summary

Alberta SPOR Graduate Studentship in Patient-Oriented Research. Program Guide

Establishment of clinical criteria: Best practice, clinical guidelines and patient pathways

Technology Appraisal Programme of the National Institute for Clinical Excellence A review by WHO

NICE guideline 5: Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes

Clinical audit: a guide

NCLEX-RN: 2015 performance of Alberta graduates. College & Association of Registered Nurses of Alberta

Evidence-Based Practice for Nursing

Framework for the development of Consultant Practitioner Posts

Final Accreditation Report

teeth in the NHS Constitution: the case of the right to NICE approved treatments The by Don Redding Director of Policy, National Voices

O1 Readiness. O2 Implementation. O3 Success A FRAMEWORK TO EVALUATE MUSCULOSKELETAL MODELS OF CARE

PPI in Evaluation. Examples of Good Practice taken from the Survey

Northern Ireland Clinical Research Network

Pharmacist (Palliative Care) December 2014 Page 1

1. Introduction, purpose of this Standard Operating Procedure (SOP)

Letter from our team. By Patty Thille for the Canadian Collaboration for Immigrant and Refugee Health

1. Introduction, purpose of this Standard Operating Procedure (SOP)

InterTASC ISSG Workshop 9th July 2014 Exeter

BGS Response to LACDP System Wide Response (

Annual Report Summary 2016/17

Drug Safety and Effectiveness Network

Membership of Oral health for adults in care homes public health advisory committee

This article is Part 1 of a two-part series designed. Evidenced-Based Case Management Practice, Part 1. The Systematic Review

A SHORT HISTORY OF INAHTA

Proposed amendments to the Marihuana for Medical Purposes Regulations

Collaboration & Teamwork

Process and methods Published: 30 November 2012 nice.org.uk/process/pmg6

NHS Evidence: an introduction.

Scottish Medicines Consortium. A Guide for Patient Group Partners

A SINGLE ENTITY FOR HTA IN SOUTH AFRICA?

Recognition of Health Informatics in Australian Standard Classifications for Research, Occupation and Education

CIHR Project Scheme 1 st Live Pilot Workshop. Office of the Vice Dean Research and Innovation. Faculty of Medicine. Questions and Answers

Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31

Social Work Education and Training. Specified Named Course Requirements: Approved Mental Health Professional

Policy Forum Health Technology Policy Options Renal Replacement Therapy in Critical Care

CERTIFIED PRACTISING ECOLOGICAL CONSULTANT

Robot-Assisted Surgeries A Project for CADTH, a Decision for Jurisdictions

Advanced Roles for Nurses: Clinical Nurse Specialists and Nurse Practitioners

Non-Medical Prescribing

Standards of Practice for. Recreation Therapists. Therapeutic Recreation Assistants

Transcription:

Consumer Involvement in decision making for health care policy and planning Nancy Santesso Cochrane Musculoskeletal Group Anne Dooley Canadian Arthritis Patient Alliance

Levels of consumer participation Individual patient working with physician to make health care decisions, self-management Community patient involved in patient groups, local hospital committees Population involvement in decisions that will affect a population of people health care policy and planning (e.g. HTA) Clinical practice (e.g. guidelines) Clinical research (e.g. ethics) Patient information (e.g. for personal health care decisions)

Why do it? Does it work? FOR: voice of the people directly affected by the decisions and services Voice of those living with the disease on day to day basis may lead to more accessible and acceptable health services improve health and quality of life lead to health research of greater quality and clinical relevance

Why do it? Does it work? AGAINST: makes research projects costlier makes research projects longer consumers may have biased views on certain health issues consumers may represent themselves not a group Cochrane systematic review pending: Interventions for promoting consumer involvement in developing healthcare policy and research, clinical practice guidelines and patient information material ES Nilsen, HT Myrhaug, M Johansen, S Oliver, AD Oxman

Anyone doing it? UK: NICE NICE technology appraisal recommendations are prepared by an independent committee called the Technology Appraisal Committee. Committee members include: the NHS patient and carer organisations academia pharmaceutical and medical devices industries UK: NCCHTA help to identify and prioritise research topics. comment on research proposals, help inform the research question and the extent of the health problem, comment on reports Australia: Medical Services Advisory Committee (MSAC) consists largely of doctors and health economists, exceptions are people nominated to represent consumers interests US: AHRQ - National Advisory Council for Healthcare Research and Quality include individuals representing the interests of patients and consumers of health care

Key Opportunities in HTA process and Drug Review HTA PROCESS Step 1: Selecting topics Step 2: Defining the research question Step 3: Forming a project team - Scientific Advisory Panel. Step 4: Assembling the evidence Step 5: Synthesizing and interpreting the evidence clinical relavance? Step 6: Reviewing the report Canadian Expert Drug Advisory Committee (CEDAC) - an independent advisory body comprised of individuals with expertise in drug therapy and drug evaluation. - makes recommendations to each of the participating federal, provincial and territorial publicly-funded drug plans regarding the listing of drugs on their formularies. Decision Making Committees Step 7: Knowledge Transfer

What do they want to do? In Canada, interviews with approx 50 health consumer organisations about how would like to participate in the HTA process showed that 100% wanted information 70% want to participate in other ways 70 to 80% participate as part of the research (complete surveys, interviews, focus groups, etc.) 71% would be willing to send representatives to take part in a decision-making committee Pivik J, Rode E, Ward C. A consumer involvement model for health technology assessment in Canada. Health Policy. 2004 Aug;69(2):253-68.

How to do it? Avoid doing it to simply placate Avoid tokenism work to consultation with a goal of collaboration Actively recruit consumers should be linked to service user/carer networks and be able to draw on a wide body of public opinion Enable participation money, transportation Ask how they would like to participate Provide training - technical knowledge and skills about research and HTA process, health issues and policies VIA workshops, manuals, guidelines on the internet

Does it work? Who's doing it? The Canadian Experience The Canadian arthritis patient community knows it works. We're doing it! Canadian Arthritis Network (CAN) requires patient involvement in all CAN funded research - CIHR Institute of Musculoskeletal Health and Arthritis and other groups encourage involvement Canadian Arthritis Network-Consumer Advisory Council - provides patient input into research -members on internal CAN committees to manage multi-million $$ Network Centre of Excellence. Consumer members of grant Peer Review Panels

The Canadian Experience CMSG consumers: peer reviewers, consumer reviewers and members of CCNet Participation in COMPUS Workshops across Canada 2004 CAN Annual Scientific Conferences; Participation in CRA Annual Meetings; CAN Informatics and Ethics Workshop Participation in Towards a National Pharmaceutical Strategy-2006 Consumer involvement in HC Expert COX-2 Panel

COX-2 Panel Health Canada Expert Advisory Panel (EAP) on selective COX-2 NSAIDs First time Health Canada invites public to present before an EAP First inclusion of patients as members of EAP Panel examined issues regarding risks of COX-2's versus benefits associated with their risks. Received: 65 written submissions from individuals 7 submissions from organizations

COX-2 Panel Patient Panel Member contributions: Living with chronic disease the patient perspective Treatment availability/choices the patient perspective Risks vs benefits the patient perspective NSAIDs the patient perspective The case of ibuprophen

What do we want? We want to contribute to CCOHTA- Health Technology Assessment Step 6 Reviewing the Report... involves internal and external assessments that may include methodologists, clinicians and industry. Suggestion: Include patients who are part of the disease group most affected by the information.

What do we want? We want to contribute: to health care planning to design and planning of National Pharmaceutical Strategy Through consultations by NPS task force with all stakeholders groups including patients Patients do not accept that universal health care can be affirmed in theory, but denied in practice. Theory and practice meet in collaboration.

Does collaboration work? Yes it can! If you: Don't placate it doesn't work Forget tokenism it's counter productive Recruit organizations and coalitions we have the members, networks, knowledge and interest Enable our participation funding is important Provide training goals; technical knowledge and skills

... CCOHTA is considering methods of greater public involvement in CDR; this cannot occur soon enough. Andrea Laupacis, CMAJ, January 31, 2006